0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

BRAF Targets in Melanoma - Biological Mechanisms, Resistance, and Drug Discovery (Hardcover, 2015 ed.) Loot Price: R3,279
Discovery Miles 32 790
You Save: R722 (18%)
BRAF Targets in Melanoma - Biological Mechanisms, Resistance, and Drug Discovery (Hardcover, 2015 ed.): Ryan J. Sullivan

BRAF Targets in Melanoma - Biological Mechanisms, Resistance, and Drug Discovery (Hardcover, 2015 ed.)

Ryan J. Sullivan

Series: Cancer Drug Discovery and Development, 82

 (sign in to rate)
List price R4,001 Loot Price R3,279 Discovery Miles 32 790 | Repayment Terms: R307 pm x 12* You Save R722 (18%)

Bookmark and Share

Expected to ship within 12 - 17 working days

This volume contains a collection of writings from the leaders in the fields of Molecular Biology and Melanoma Research which will begin to tell the ever-expanding story of the most recent findings, discoveries, and potential of BRAF-directed targets in melanoma. Recent research has shown that BRAF inhibitors are effective for a short period of time, but there is little hope that this drugs as single agents will lead to durable benefit in a majority of patients. Among scientists and researchers who work in drug discovery, there is a lot of interest in the development of molecularly targeted cancer agents. Namely, the identification of a molecular target, the selection of molecules which effectively inhibit this target. What is starkly different about the development of this class of compounds, however, is that the mechanism of action of these agents are not as straightforward as was once previously assumed and the mechanisms of resistance that tumor cells employ to evade complete destruction are unlike any that have been described before. These discoveries in addition to utilization of modern molecular biology techniques have led to a series of hypotheses regarding which other types of molecules could be used in combination with BRAF-inhibitors in hopes of revolutionizing the potential of therapeutics in melanoma.

General

Imprint: HumanaPress
Country of origin: United States
Series: Cancer Drug Discovery and Development, 82
Release date: November 2014
First published: 2015
Editors: Ryan J. Sullivan
Dimensions: 235 x 155 x 13mm (L x W x T)
Format: Hardcover
Pages: 204
Edition: 2015 ed.
ISBN-13: 978-1-4939-2142-3
Categories: Books > Medicine > Clinical & internal medicine > Dermatology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4939-2142-8
Barcode: 9781493921423

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners